EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic Diseases

EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic DiseasesПодробнее

Digital ILC 2020:Immune-mediated & chronic cholestasic liver disease: Experimental & pathophysiologyПодробнее

Digital ILC 2020. Immune-mediated and chronic cholestatic liver disease - Clinical aspects.Подробнее

EASL Congress 2024 - Wrap up on Liver TumoursПодробнее

EASL Congress 2023: Explore the Immune mediated & Cholestatic Diseases Track!Подробнее

EASL Congress 2024 - Wrap up on Viral HepatitisПодробнее

EASL Congress 2024 - Wrap up on Metabolism, Alcohol & ToxicityПодробнее

EASL Congress 2024 - Wrap up on Basic ScienceПодробнее

EASL Congress 2024 - Wrap up on Cirrhosis & ComplicationsПодробнее

EASL Studio Midday Talks: Steatotic liver disease global consensus to change nomenclatureПодробнее

Episode 2 - Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliar...Подробнее

Join us at the EASL Liver Cancer Summit 2024!Подробнее

Day 2 - EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary CholangitisПодробнее

EASL Studio at EASL Congress 2024 - Exploring new frontiers: The AI liver taskforce initiativeПодробнее

Day 1 - EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary CholangitisПодробнее

Episode 1 -Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary...Подробнее

EASL Congress Day 4 - Poster testimonialПодробнее